Oral enalapril-hydrochlorothiazide-methyldopa as first line treatment for severe hypertension in Nigerians.
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000191:economics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004656:Enalapril / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D006852:Hydrochlorothiazide / Q000191:economics / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy*; D008750:Methyldopa / Q000191:economics / Q000627:therapeutic use*; D008875:Middle Aged; D009549:Nigeria; D011446:Prospective Studies; D016896:Treatment Outcome
D000959:Antihypertensive Agents; D006852:Hydrochlorothiazide; D008750:Methyldopa; D004656:Enalapril